NeuBase Therapeutics
About:
NeuBase Therapeutics develops gene silencing therapies with its synthetic antisense oligonucleotides.
Website: https://www.neubasetherapeutics.com/
Twitter/X: neubaseinc
Description:
NeuBase Therapeutics is a pre-clinical stage biopharmaceutical company that develops gene silencing therapies with its synthetic antisense oligonucleotides. It also provides a platform that focuses on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy, and Familial Parkinson's Disease, among others.
$14M
$1M to $10M
Pittsburgh, Pennsylvania, United States
2009-08-04
info(AT)neubasetherapeutics.com
Dietrich Stephan
11-50
2023-06-28
Public
© 2025 bioDAO.ai